NASDAQ:ABEO

Abeona Therapeutics Stock Predictions

etoro logo Buy ABEO
*Your capital is at risk
$5.67
-0.0200 (-0.351%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ABEO Prediction Chart

ABEO Predictions History

Latest community submissions for ABEO.
Predictor Target Session Target Price Result Direction Accuracy Score
May 26, 2026 $5.52 +1.46% $5.49 V 99.46% 4
May 26, 2026 $5.33 -1.95% $5.49 X 97.15% 0
May 26, 2026 $5.37 -1.22% $5.49 X 97.88% 0
May 26, 2026 $5.65 +3.86% $5.49 V 97.09% 1
May 12, 2026 Bullish $5.68 X 0
Apr 2, 2026 Bullish $4.82 V 1
Mar 20, 2026 Bullish $4.45 X 0
Sep 2, 2025 $6.95 +1.68% $6.85 V 98.61% 2
Sep 2, 2025 $6.90 +1.05% $6.85 V 99.24% 3
Sep 2, 2025 Bullish $6.85 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABEO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE